全文获取类型
收费全文 | 116562篇 |
免费 | 13281篇 |
国内免费 | 1201篇 |
专业分类
耳鼻咽喉 | 380篇 |
儿科学 | 2509篇 |
妇产科学 | 2124篇 |
基础医学 | 6820篇 |
口腔科学 | 4928篇 |
临床医学 | 22578篇 |
内科学 | 9743篇 |
皮肤病学 | 801篇 |
神经病学 | 6130篇 |
特种医学 | 1336篇 |
外国民族医学 | 1篇 |
外科学 | 7080篇 |
综合类 | 11919篇 |
现状与发展 | 4篇 |
一般理论 | 108篇 |
预防医学 | 40580篇 |
眼科学 | 504篇 |
药学 | 5885篇 |
149篇 | |
中国医学 | 4468篇 |
肿瘤学 | 2997篇 |
出版年
2024年 | 557篇 |
2023年 | 3692篇 |
2022年 | 4790篇 |
2021年 | 6702篇 |
2020年 | 7046篇 |
2019年 | 6539篇 |
2018年 | 5744篇 |
2017年 | 5563篇 |
2016年 | 5313篇 |
2015年 | 5099篇 |
2014年 | 7873篇 |
2013年 | 10273篇 |
2012年 | 6747篇 |
2011年 | 7389篇 |
2010年 | 5531篇 |
2009年 | 5507篇 |
2008年 | 5433篇 |
2007年 | 5365篇 |
2006年 | 4662篇 |
2005年 | 3515篇 |
2004年 | 3007篇 |
2003年 | 2680篇 |
2002年 | 1936篇 |
2001年 | 1803篇 |
2000年 | 1565篇 |
1999年 | 1095篇 |
1998年 | 939篇 |
1997年 | 762篇 |
1996年 | 619篇 |
1995年 | 445篇 |
1994年 | 397篇 |
1993年 | 394篇 |
1992年 | 311篇 |
1991年 | 258篇 |
1990年 | 225篇 |
1989年 | 173篇 |
1988年 | 192篇 |
1987年 | 129篇 |
1986年 | 114篇 |
1985年 | 128篇 |
1984年 | 86篇 |
1983年 | 57篇 |
1982年 | 53篇 |
1981年 | 46篇 |
1980年 | 59篇 |
1979年 | 37篇 |
1978年 | 39篇 |
1977年 | 41篇 |
1976年 | 35篇 |
1975年 | 37篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
《Clinical neurophysiology》2020,131(1):259-264
ObjectivesFasciculation potentials (FP) are an important consideration in the electrophysiological diagnosis of ALS. Muscle ultrasonography (MUS) has a higher sensitivity in detecting fasciculations than electromyography (EMG), while in some cases, it is unable to detect EMG-detected fasciculations. We aimed to investigate the differences of FP between the muscles with and without MUS-detected fasciculations (MUS-fas).MethodsThirty-one consecutive patients with sporadic ALS were prospectively recruited and in those, both needle EMG and MUS were performed. Analyses of the amplitude, duration, and number of phases of EMG-detected FPs were performed for seven muscles per patient, and results were compared between the muscles with and without MUS-fas in the total cohort.ResultsThe mean amplitude and phase number of FP were significantly lower in patients with EMG-detected FP alone (0.39 ± 0.25 mV and 3.21 ± 0.88, respectively) than in those with both FP and MUS-fas (1.22 ± 0.92 mV and 3.74 ± 1.39, respectively; p < 0.0001 and p = 0.017, Welch’s t-test).ConclusionSmall FP may be undetectable with MUS. MUS cannot replace EMG in the diagnostic approach for ALS.SignificanceClinicians should use a combination of EMG and MUS for the detection and quantitative analysis of fasciculation in ALS. 相似文献
52.
《Journal of vascular and interventional radiology : JVIR》2020,31(6):869-875
This paper describes country-wide special measures undertaken for interventional radiology staff during the current coronavirus disease 2019 (COVID-19) pandemic. Although each interventional radiology service around the world faces unique challenges, the principles outlined in this article will be useful when designing or strengthening individual practices and integrating them within wider hospital and national measures. Moving beyond the current outbreak, these measures will be useful for any future infectious diseases which are likely to arise. 相似文献
53.
54.
55.
56.
57.
58.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies
下载免费PDF全文
![点击此处可从《Journal of viral hepatitis》网站下载免费的PDF全文](/ch/ext_images/free.gif)
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献
59.
60.
对微信平台在住院病人健康教育中的应用现状进行总结,分析其目前成果、平台构建现状与存在的问题,为医院护理人员进行健康宣教提供参考。 相似文献